{"nct_id":"NCT00913835","title":"A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer","status":"COMPLETED","status_verified_date":"2019-09","start_date":"2009-06","start_date_type":null,"primary_completion_date":"2011-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}